Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹17098 Cr.
Stock P/E
21.3
P/B
5.8
Current Price
₹391.7
Book Value
₹ 67
Face Value
1
52W High
₹634.7
52W Low
₹ 385.4
Dividend Yield
2.55%

Emami Overview

Business

Emami Ltd. is an Indian fast-moving consumer goods (FMCG) company engaged in the manufacturing and marketing of a diverse range of personal care and healthcare products. Its core business model involves developing, producing, and distributing branded products primarily across India, but also in some international markets. The company makes money by selling these products through a vast multi-channel distribution network, including traditional retail, modern trade, and increasingly, e-commerce platforms, leveraging strong brand recognition and extensive market reach.

Revenue Mix

Emami's product portfolio broadly falls into:

Personal Care: Includes categories like antiseptic creams (Boroplus), cooling oils (Navratna), men's fairness creams (Fair and Handsome), deodorants, talcum powders, and lotions.

Healthcare: Comprises pain balms (Zandu Balm), Ayurvedic remedies (Zandu Chyawanprash, Zandu Pancharishta), and antiseptic liquids.

While specific recent percentage breakdowns can vary, historically, cooling oils, antiseptic creams, and pain balms have been significant contributors, leveraging long-established brands. The company also has a presence in niche categories like male grooming.

Industry

Emami operates in the highly competitive Indian Household & Personal Products industry, which is characterized by a mix of large multinational corporations (e.g., HUL, P&G), well-established domestic players (e.g., Dabur, Marico, Godrej Consumer), and numerous regional and unorganized players. The industry is driven by population growth, rising disposable incomes, and evolving consumer preferences. Emami positions itself as a significant mid-tier player, particularly strong in specific niche categories (e.g., Ayurvedic pain balms, cooling oils, antiseptic creams) and mass-market segments. It often competes on a combination of brand legacy, value-for-money propositions, and extensive rural penetration.

MOAT

Brand Equity & Recognition: Emami possesses a portfolio of well-established and trusted brands such as Navratna, Boroplus, Zandu, and Fair and Handsome, which have strong recall and consumer loyalty built over decades.

Extensive Distribution Network: A deep and wide distribution network, crucial for FMCG success in India, reaching millions of retail outlets across urban and rural areas.

Ayurvedic Heritage: A strong foundation and expertise in Ayurvedic formulations, particularly through brands like Zandu, which resonates with consumers seeking natural and traditional remedies.

Cost Efficiency & Mass-Market Focus: Ability to offer products at competitive price points, making them accessible to a broad consumer base.

Growth Drivers

Rising Disposable Incomes: Growth in per capita income and consumer spending in India, particularly in semi-urban and rural areas.

Premiumization & Innovation: Launching new products and variants in existing categories to cater to evolving consumer preferences for natural, organic, and specialized products, and moving up the value chain.

Rural Market Penetration: Deepening reach in India's vast rural markets, which are experiencing faster growth in consumption.

E-commerce & Digital Channels: Expanding presence and sales through online platforms and direct-to-consumer (D2C) strategies.

Health & Wellness Trend: Capitalizing on the increased consumer focus on health, hygiene, and immunity-boosting products, aligning with its Ayurvedic strengths.

Risks

Intense Competition: High competitive intensity from both larger domestic and multinational FMCG players, and emerging D2C brands, leading to price wars or increased marketing spends.

Raw Material Price Volatility: Fluctuations in the cost of key raw materials (e.g., menthol, paraffin, essential oils, packaging materials) can impact gross margins.

Demand Slowdown: Economic downturns, high inflation, or adverse climatic conditions can impact discretionary spending on personal care products.

Regulatory Changes: Stricter regulations related to product ingredients, advertising claims, or environmental compliance.

Brand Relevance: Failure to innovate or adapt quickly to changing consumer trends can lead to brand fatigue and loss of market share.

Management & Ownership

Emami Ltd. is a promoter-driven company, founded by Mr. R.S. Agarwal and Mr. R.S. Goenka. The promoter group, which holds a significant majority stake, continues to be actively involved in the management, with the next generation gradually taking on leadership roles. Management quality is generally seen as experienced in the Indian FMCG landscape, known for a focus on traditional marketing and distribution strengths, alongside efforts to modernize and adapt to new market dynamics.

Outlook

Emami benefits from a strong portfolio of heritage brands and an established distribution network in the resilient Indian FMCG sector. Its deep penetration in rural markets and expertise in Ayurvedic products provide a defensive moat. The company's future growth trajectory will largely depend on its ability to successfully innovate and premiumize its offerings, effectively expand its presence in digital channels, and manage the intense competitive landscape without significant margin erosion. While its focus on health and wellness aligns with prevailing consumer trends, navigating raw material inflation and adapting to evolving consumer preferences will be critical to sustaining growth and profitability.

Emami Share Price

Live · BSE / NSE · Inception: 1995
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Emami Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 996 891 906 891 1049 963 904 799 1152 925
Other Income 17 11 10 22 15 21 22 21 19 23
Total Income 1013 902 917 912 1064 984 926 820 1171 948
Total Expenditure 681 680 690 640 711 744 690 620 768 738
Operating Profit 332 222 227 272 354 241 236 200 403 210
Interest 3 3 2 2 2 3 2 3 3 3
Depreciation 46 48 44 45 46 44 45 45 45 42
Exceptional Income / Expenses -6 0 0 0 0 0 0 0 -10 0
Profit Before Tax 277 171 180 225 306 194 189 152 345 164
Provision for Tax 15 22 28 9 22 32 23 2 26 21
Profit After Tax 262 148 153 216 283 163 166 150 319 144
Adjustments -3 1 -0 -3 -4 -1 -2 -2 0 -0
Profit After Adjustments 258 149 153 213 279 162 164 148 319 143
Adjusted Earnings Per Share 5.9 3.4 3.5 4.9 6.4 3.7 3.8 3.4 7.3 3.3

Emami Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 2217 2358 2488 2531 2695 2655 2881 3187 3406 3578 3809 3780
Other Income 182 109 89 96 35 57 70 95 69 47 68 85
Total Income 2400 2468 2577 2627 2730 2712 2951 3282 3475 3625 3877 3865
Total Expenditure 1768 1736 1787 1888 1967 1964 1997 2235 2543 2629 2784 2816
Operating Profit 632 732 790 739 762 748 953 1048 932 996 1093 1049
Interest 5 54 58 34 21 21 13 5 7 10 9 11
Depreciation 34 255 309 311 325 336 367 335 247 186 178 177
Exceptional Income / Expenses 0 0 0 0 -10 -11 0 -5 0 -6 0 -10
Profit Before Tax 592 423 424 393 403 374 569 688 670 791 894 850
Provision for Tax 107 60 84 86 101 71 114 -149 42 67 91 72
Profit After Tax 485 363 340 306 303 302 455 837 627 724 803 779
Adjustments 0 0 0 1 1 1 -0 2 12 -1 4 -4
Profit After Adjustments 486 364 340 307 303 303 455 839 640 724 806 774
Adjusted Earnings Per Share 10.7 8 7.5 6.8 6.7 6.7 10.2 19 14.5 16.6 18.5 17.8

Emami Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1231 1612 1755 2014 2076 1824 1763 2077 2303 2447 2695
Minority's Interest 5 4 1 1 -0 -1 -1 -2 10 11 -1
Borrowings 2 300 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 53 42 65 70 63 64 58 -216 -290 -375 -463
Total Current Liabilities 387 735 782 714 680 792 700 916 724 759 779
Total Liabilities 1676 2692 2603 2798 2819 2678 2520 2774 2746 2842 3010
Fixed Assets 453 1918 1940 1746 1625 1405 1079 1290 1192 1062 933
Other Non-Current Assets 80 269 222 351 344 240 314 411 267 362 343
Total Current Assets 1143 505 441 701 849 1033 1127 1073 1287 1418 1734
Total Assets 1676 2692 2603 2798 2819 2678 2520 2774 2746 2842 3010

Emami Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 268 350 101 28 16 116 11 20 28 47 53
Cash Flow from Operating Activities 534 562 730 588 554 531 922 644 749 779 896
Cash Flow from Investing Activities -234 -1306 -297 -279 -23 -228 -227 -235 -113 -205 -340
Cash Flow from Financing Activities -215 502 -496 -324 -428 -405 -688 -402 -608 -563 -500
Net Cash Inflow / Outflow 85 -243 -64 -15 103 -102 6 7 28 11 56
Closing Cash & Cash Equivalent 350 101 28 16 116 11 20 28 47 53 105

Emami Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 10.7 8.01 7.5 6.77 6.68 6.68 10.23 19.02 14.5 16.58 18.48
CEPS(Rs) 11.45 13.61 14.29 13.6 13.83 14.09 18.48 26.55 19.83 20.85 22.47
DPS(Rs) 7 7 7 7 4 4 8 8 8 8 10
Book NAV/Share(Rs) 27.11 35.5 38.66 44.36 45.73 40.24 39.65 47.07 52.2 56.05 61.74
Core EBITDA Margin(%) 19.92 25.97 27.74 25.3 26.99 26.01 30.66 29.88 25.33 26.54 26.91
EBIT Margin(%) 26.48 19.89 19.05 16.8 15.77 14.86 20.21 21.75 19.88 22.38 23.71
Pre Tax Margin(%) 26.25 17.63 16.76 15.45 14.97 14.07 19.75 21.59 19.66 22.1 23.47
PAT Margin (%) 21.51 15.14 13.45 12.05 11.23 11.39 15.79 26.25 18.42 20.24 21.07
Cash Profit Margin (%) 23.03 25.78 25.66 24.29 23.3 24.05 28.52 36.75 25.68 25.43 25.75
ROA(%) 32.6 16.62 12.84 11.34 10.77 11 17.49 31.61 22.73 25.92 27.44
ROE(%) 44.89 25.55 20.2 16.26 14.79 15.5 25.36 43.58 28.65 30.49 31.23
ROCE(%) 53.44 26.87 21.36 18.69 18.77 18.7 29.94 33.04 28.7 32.76 34.28
Receivable days 14.64 17.71 16.45 18.17 25.21 36.05 34.2 31.65 39.41 46.35 45.3
Inventory Days 21.66 21.1 23.8 26.8 28.15 32.06 34.54 37.68 36.74 33.23 30.26
Payable days 78.67 99.31 100 96.16 105.46 128.28 132.6 129.16 123.94 135.51 136.04
PER(x) 46.99 58.11 70.33 78.92 59.88 25.43 47.67 23.55 24.72 25.88 31.37
Price/Book(x) 18.54 13.11 13.65 12.04 8.75 4.22 12.3 9.51 6.87 7.65 9.39
Dividend Yield(%) 0.7 0.75 0.66 0.66 1 2.35 1.64 1.79 2.23 1.87 1.73
EV/Net Sales(x) 10.15 9.2 9.79 9.68 6.7 2.94 7.43 6.24 4.61 5.19 6.59
EV/Core EBITDA(x) 35.61 29.64 30.83 33.14 23.7 10.43 22.46 19 16.85 18.65 22.95
Net Sales Growth(%) 21.78 6.36 5.5 1.7 6.48 -1.48 8.5 10.65 6.86 5.06 6.46
EBIT Growth(%) 29.2 -20.21 1.01 -11.37 -0.48 -7.12 47.55 19.05 -2.33 18.3 12.79
PAT Growth(%) 20.63 -25.21 -6.35 -9.91 -1.23 -0.08 50.41 84 -25.01 15.42 10.86
EPS Growth(%) 20.66 -25.14 -6.36 -9.78 -1.27 0.06 53.03 85.92 -23.77 14.33 11.46
Debt/Equity(x) 0.03 0.42 0.27 0.16 0.05 0.12 0.05 0.13 0.03 0.03 0.02
Current Ratio(x) 2.96 0.69 0.56 0.98 1.25 1.3 1.61 1.17 1.78 1.87 2.22
Quick Ratio(x) 2.63 0.48 0.33 0.71 0.92 1 1.18 0.78 1.32 1.44 1.83
Interest Cover(x) 116.24 8.82 8.3 12.44 19.85 18.78 43.87 136.62 91.58 80.26 96.73
Total Debt/Mcap(x) 0 0.03 0.02 0.01 0.01 0.03 0 0.01 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +6% +6% +7% +6%
Operating Profit CAGR +10% +1% +8% +6%
PAT CAGR +11% -1% +22% +5%
Share Price CAGR -33% 0% -6% -3%
ROE Average +31% +30% +32% +27%
ROCE Average +34% +32% +32% +29%

Emami Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 54.84 %
FII 8.58 %
DII (MF + Insurance) 26.92 %
Public (retail) 45.16 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 54.8454.8454.8454.8454.8454.8454.8454.8454.8454.84
FII 12.8613.4614.0214.3814.1112.1111.8910.939.038.58
DII 23.9522.0721.6121.521.723.6724.0625.0126.7326.92
Public 45.1645.1645.1645.1645.1645.1645.1645.1645.1645.16
Others 0000000000
Total 100100100100100100100100100100

Emami Peer Comparison

Household & Personal Products Edit Columns

Emami Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Emami Pros & Cons

Pros

  • Company has delivered good profit growth of 21% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 30%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 135.51 to 136.04days.
  • Stock is trading at 5.8 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp